The Leadership Team at Scantox Group oversees strategic decision-making, operational management, financial oversight, and scientific direction to ensure the organization excels in delivering top-tier preclinical contract research services. Comprising key executives including the CEO, COO, CFO, Chief Commercial Officer, Chief Scientific Officer, and the Chief Operating Officer at Scantox Sweden, this team ensures the seamless integration of regulatory toxicology and pharmacology expertise to accelerate clients' drug and device development.